Meeting
2021 Genitourinary Cancers Symposium
The prognostic significance of homologous recombination repair pathway alterations in metastatic hormone-sensitive prostate cancer.
Authors
Justin Shaya
University of California San Diego, Moores Cancer Center, La Jolla, CA
Justin Shaya , Aaron Lee , Angelo Cabal , Justine Panian , James Michael Randall , Frederick E. Millard , Tyler Francis Stewart , Brent S. Rose , John Kellogg Parsons , Rana R. McKay
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Advanced Disease
Track
Prostate Cancer - Advanced
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 150)
DOI
10.1200/JCO.2021.39.6_suppl.150
Abstract #
150
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Treatment outcomes for patients (Pts) with metastatic castration resistant prostate cancer (mCRPC) pts and DNA damage repair gene mutations.
First Author: Steven Yip
Poster
2023 ASCO Annual Meeting
Final results of a pilot study of docetaxel and carboplatin for treatment of patients with mCRPC containing biallelic inactivation of genes in the homologous recombination DNA repair pathway.
First Author: Ruben Raychaudhuri
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan